The effect of poly(D,L-lactide-co-glycolide)-alendronate conjugate nanoparticles on human osteoclast precursors

Journal of Biomaterials Science, Polymer Edition

Volumn 23, Issue 10, 2012, Pages 1285-1300

  Cenni, Elisabetta ^a   Avnet, Sofia ^a   Granchi, Donatella ^a   Fotia, Caterina ^a   Salerno, Manuela ^a   Micieli, Dorotea ^b   Sarpietro, Maria Grazia ^b   Pignatello, Rosario ^b   Castelli, Francesco ^b   Baldini, Nicola ^a,c  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Bisphosphonate; Bone targeting; Nanoparticle; Osteoclast; Poly(D,L lactide co glycolide)

Indexed keywords

ACTIVITY-DEPENDENT; ALENDRONATE; BISPHOSPHONATES; BONE METASTASIS; DOXORUBICIN; OSTEOCLAST; OSTEOCLAST PRECURSOR; POLY(D ,L-LACTIDE-CO- GLYCOLIDE); TYPE-I COLLAGEN;

BONE; CELL DEATH; COLLAGEN; CONJUGATED POLYMERS; LOADING; NANOPARTICLES; TUMORS;

COPOLYMERS;

ACTIN; ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; COLLAGEN TYPE 1; DOXORUBICIN; NANOPARTICLE; POLYGLACTIN; BONE DENSITY CONSERVATION AGENT; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

APOPTOSIS; ARTICLE; BONE DEFECT; BONE METASTASIS; BONE TUMOR; COLLAGEN DEGRADATION; CONTROLLED STUDY; DRUG CONJUGATION; DRUG DEGRADATION; DRUG EFFECT; DRUG TARGETING; HUMAN; HUMAN CELL; OSTEOCLAST; OSTEOLYTIC BONE METASTASIS; PRIORITY JOURNAL; STEM CELL; BONE NEOPLASMS; CELL CULTURE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; PROTEIN DEGRADATION; PROTON NUCLEAR MAGNETIC RESONANCE;

ACTINS; ALENDRONATE; APOPTOSIS; BONE DENSITY CONSERVATION AGENTS; BONE NEOPLASMS; CELLS, CULTURED; COLLAGEN TYPE I; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LACTIC ACID; NANOPARTICLES; OSTEOCLASTS; POLYGLYCOLIC ACID; PROTEOLYSIS; PROTON MAGNETIC RESONANCE SPECTROSCOPY;

EID: 84867225075     PISSN: 09205063     EISSN: 15685624     Source Type: Journal    
DOI: 10.1163/092050611X580373     Document Type: Article

References (49)

1. D. Wang, S. C. Miller, P. Kopeckova and J. Kopecek, Adv. Drug Deliv. Rev. 57, 1049 (2005).
2. S. Zhang, G. Gangal and H. Uludag, Chem. Soc. Rev. 36, 507 (2007).
3. K. Su, X. Shi, R. R. Varshney and D. A. Wang, Expert Opin. Drug Deliv. 8, 113 (2011).
4. K. Ogawa, T. Mukai, Y. Inoue, M. Ono and H. Saji, J. Nucl. Med. 47, 2042 (2006).
5. T. J. Houghton, K. S. Tanaka, T. Kang, E. Dietrich, Y. Lafontaine, D. Delorme, S. S. Ferreira, F. Viens, F. F. Arhin, I. Sarmiento, D. Lehoux, I. Fadhil, K. Laquerre, J. Liu, V. Ostiguy, H. Poirier, G. Moeck, T. R. Parr Jr. and A. R. Far, J. Med. Chem. 51, 6955 (2008).
6. M. R. Doschak, C. M. Kucharski, J. E. Wright, R. F. Zernicke and H. Uludaǧ, Mol. Pharm. 6, 634 (2009).
7. S. W. Choi and J. H. Kim, J. Control. Rel. 122, 24 (2007).
8. X. Shi, Y. Wang, R. R. Varshney, L. Ren, F. Zhang and D. A. Wang, Biomaterials 30, 3996 (2009).
9. K. K. Jain, BMC Med. 8, 83 (2010).
10. J. C. Clark, C. R. Dass and P. F. Choong, Expert Opin. Emerg. Drugs 13, 609 (2008).
11. A. Albini, G. Pennesi, F. Donatelli, R. Cammarota, S. De Flora and D. M. Noonan, J. Natl. Cancer Inst. 102, 14 (2010).
12. E. Ruoslahti, S. N. Bhatia and M. J. Sailor, J. Cell. Biol. 188, 759 (2010).
13. R. E. Coleman, A. Lipton, G. D. Roodman, T. A. Guise, B. F. Boyce, A. M. Brufsky, P. Clézardin, P. I. Croucher, J. R. Gralow, P. Hadji, I. Holen, G. R. Mundy, M. R. Smith and L. J. Suva, Cancer Treat. Rev. 36, 615 (2010).
14. M. Salerno, E. Cenni, C. Fotia, S. Avnet, D. Granchi, F. Castelli, D. Micieli, R. Pignatello, M. Ca-pulli, N. Rucci, A. Angelucci, A. Del Fattore, A. Teti, N. Zini, A. Giunti and N. Baldini, Curr. Cancer Drug Targets 10, 649 (2010).
15. X. M. Liu, A. T. Wiswall, J. E. Rutledge, M. P. Akhter, D. M. Cullen, R. A. Reinhardt and D. Wang, Biomaterials 29, 1686 (2008).
16. D. W. Dempster, C. E. Hughes-Begos, K. Plavetic-Chee, A. Brandao-Burch, F. Cosman, J. Nieves, S. Neubort, S. S. Lu, A. Iida-Klein, T. Arnett and R. Lindsay, J. Cell. Biochem. 95, 139 (2005).
17. H. K. Väänänen and T. Laitala-Leinonen, Arch. Biochem. Biophys. 473, 132 (2008).
18. R. Pignatello, E. Cenni, D. Micieli, C. Fotia, M. Salerno, D. Granchi, S. Avnet, M. G. Sarpietro, F. Castelli and N. Baldini, Nanomedicine 4, 161 (2009).
19. D. Granchi, I. Amato, L. Battistelli, G. Ciapetti, S. Pagani, S. Avnet, N. Baldini and A. Giunti, Biomaterials 26, 2371 (2005).
20. S. Holmes, S. Smith, L. Borthwick, J. Dunford, M. Rogers, N. Bishop and P. S. Grabowski, Biochem. Biophys. Res. Commun. 365, 840 (2008).
21. C. Shi, M. Sakuma, T. Mooroka, A. Liscoe, H. Gao, K. J. Croce, A. Sharma, D. Kaplan, D. R. Greaves, Y. Wang and D. I. Simon, Blood 112, 4699 (2008).
22. M. Loi, S. Marchiò, P. Becherini, D. Di Paolo, M. Soster, F. Curnis, C. Brignole, G. Pagnan, P. Perri, I. Caffa, R. Longhi, B. Nico, F. Bussolino, C. Gambini, D. Ribatti, M. Cilli, W. Arap, R. Pasqualini, T. M. Allen, A. Corti, M. Ponzoni and F. Pastorino, J. Control. Rel. 145, 66 (2010).
23. S. Rai, R. Paliwal and S. P. Vyas, J. Biomed. Nanotechnol. 7, 121 (2011).
24. E. Ruoslahti, S. N. Bhatia and M. J. Sailor, J. Cell. Biol. 188, 759 (2010).
25. G. Wang, C. Kucharski, X. Lin and H. Uludaǧ, J. Drug Target. 18, 611 (2010).
26. P. T. Lakkakorpi and H. K. Väänänen, Microsc. Res. Tech. 33, 171 (1996).
27. K. Suzuki, S. Takeyama, Y. Sakai, S. Yamada and H. Shinoda, J. Pharmacol. Sci. 100, 189 (2006).
28. J. W. Lee, N. Mase, T. Yonezawa, H. J. Seo, W. B. Jeon, B. Y. Cha, K. Nagai and J. T. Woo, Biol. Pharm. Bull. 33, 1733 (2010).
29. J. M. Halasy-Nagy, G. A. Rodan and A. A. Reszka, Bone 29, 553 (2001).
30. M. B. Martin, W. Arnold, H. T. Heath 3rd, J. A. Urbina and E. Oldfield, Biochem. Biophys. Res. Commun. 263, 754 (1999).
31. F. Watari, N. Takashi, A. Yokoyama, M. Uo, T. Akasaka, Y. Sato, S. Abe, Y. Totsuka and K. Tohji, J. Roy. Soc. Interface 6 (Suppl. 3), S371 (2009).
32. D. E. James, B. J. Nestor, T. P. Sculco, L. B. Ivashkiv, F. P. Ross, S. R. Goldring and P. E. Purdue, J. Immunol. 185, 1265 (2010).
33. G. Sharma, D. T. Valenta, Y. Altman, S. Harvey, H. Xie, S. Mitragotri and J. W. Smith, J. Control. Rel. 147, 408 (2010).
34. C. Fang, B. Shi, Y. Y. Pei, M. H. Hong, J. Wu and H. Z. Chen, Eur. J. Pharm. Sci. 27, 27 (2006).
35. H. D. Danenberg, I. Fishbein, H. Epstein, J. Waltenberger, E. Moerman, J. Mönkkönen, J. Gao, I. Gathi, R. Reichi and G. Golomb, J. Cardiovasc. Pharmacol. 42, 671 (2003).
36. X. Shi, Y. Wang, L. Ren, Y. Gong and D. A. Wang, Pharm. Res. 26, 422 (2009).
37. E. Cenni, D. Granchi, S. Avnet, C. Fotia, M. Salerno, D. Micieli, M. G. Sarpietro, R. Pignatello, F. Castelli and N. Baldini, Biomaterials 29, 1400 (2008).
38. M. J. Oursler, J. Cell. Biochem. 110, 1058 (2010).
39. G. Iino, K. Nishimura, K. Omura and S. Kasugai, Int. J. Oral Maxillofac. Implants 23, 835 (2008).
40. I. Bala, S. Hariharan and M. N. Kumar, Crit. Rev. Ther. Drug Carr. Syst. 21, 387 (2004).
41. M. Blanco-Prieto, M. A. Campanero, K. Besseghir, F. Heimgatner and B. Gander, J. Control. Rel. 96, 437 (2004).
42. E. Cohen-Sela, O. Rosenzweig, J. Gao, H. Epstein, I. Gati, R. Reich, H. D. Danenberg and G. Golomb, J. Control. Rel. 113, 23 (2006).
43. E. C. Gryparis, M. Hatziapostolou, E. Papadimitriou and K. Avgoustakis, Eur. J. Pharm. Bio-pharm. 67, 1 (2007).
44. H. J. Knowles and N. A. Athanasou, J. Pathol. 218, 256 (2009).
45. M. Ito, N. Amizuka, T. Nakajima and H. Ozawa, Bone 25, 447 (1999).
46. K. A. Sutherland, H. L. Rogers, D. Tosh and M. J. Rogers, Arthritis Res. Ther. 11, R58 (2009).
47. J. Sun and T. Ding, J. Biomed. Mater. Res. A 88, 673 (2009).
48. M. A. Chellaiah, N. Soga, S. Swanson, S. McAllister, U. Alvarez, D. Wang, S. F. Dowdy and K. A. Hruska, J. Biol. Chem. 275, 11993 (2000).
49. Q. Zhang, I. R. Badell, E. M. Schwarz, K. E. Boulukos, Z. Yao, B. F. Boyce and L. Xing, Arthritis Rheum. 52, 2708 (2005).